Cargando…

Methotrexate toxicity treated with continuous venovenous hemofiltration, leucovorin and glucarpidase

High-dose methotrexate (MTX) can produce acute kidney injury, impairing MTX elimination. Continuous venovenous hemofiltration (CVVH) may enhance elimination in this setting, although its use is largely unstudied. A 79-year-old man received IV MTX for central nervous system lymphoma, and over a 34-h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Connors, Nicholas J., Sise, Meghan E., Nelson, Lewis S., Hoffman, Robert S., Smith, Silas W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389132/ https://www.ncbi.nlm.nih.gov/pubmed/25859377 http://dx.doi.org/10.1093/ckj/sfu093

Ejemplares similares

High-dose continuous venovenous hemofiltration combined with charcoal hemoperfusion for methotrexate removal
por: Grafft, Carrie, et al.
Publicado: (2011)

Glucarpidase to combat toxic levels of methotrexate in patients
por: Green, Jacalyn M
Publicado: (2012)

The effects of continuous venovenous hemofiltration on coagulation activation
por: Bouman, Catherine SC, et al.
Publicado: (2006)

The removal of cystatin C during continuous venovenous hemofiltration
por: Bouman, Catherine S. C., et al.
Publicado: (2011)

Severe Carbamazepine Toxicity Treated with Continuous Venovenous Hemofiltration at Palestine Medical Complex: Two Case Reports
por: Nasif, Mowaffaq A, et al.
Publicado: (2022)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Comparing adsorption of gentamicin by polyacrylonitrile and polyamide hemofiltration filter in an in vitro continuous venovenous hemofiltration model
por: Lam, P, et al.
Publicado: (2009)

Influence of continuous venovenous hemofiltration on transpulmonary thermodilution-derived parameters
por: Neirynck, V, et al.
Publicado: (2009)

Bioenergetic Balance of Continuous Venovenous Hemofiltration, a Retrospective Analysis
por: Jonckheer, Joop, et al.
Publicado: (2022)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data
por: Servillo, Giuseppe, et al.
Publicado: (2013)

Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study
por: de Pont, Anne-Cornélie JM, et al.
Publicado: (2007)

Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
por: Peng, Lengyue, et al.
Publicado: (2021)

Therapeutic plasma exchange combined with continuous venovenous hemofiltration in a series of pediatric patients with toxic epidermal necrolysis
por: Cui, Yun, et al.
Publicado: (2021)

Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study
por: Sun, Zhiping, et al.
Publicado: (2014)

Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis
por: Kala, Jaya, et al.
Publicado: (2023)

Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury
por: Heuschkel, Sandra, et al.
Publicado: (2021)

Metabolism of Albumin after Continuous Venovenous Hemofiltration in Patients with Systemic Inflammatory Response Syndrome
por: Chen, Yu, et al.
Publicado: (2015)

Metabolic Acidosis and Hyperlactatemia Requiring Continuous Venovenous Hemofiltration after Intentional Ingestion of Metformin
por: Cruz, Maricel Dela, et al.
Publicado: (2021)

Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available
por: Rosales, Alejandra, et al.
Publicado: (2021)

Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study
por: Chung, Kevin K, et al.
Publicado: (2009)

Experience with continuous venovenous hemofiltration (CVVH) in the ICU: a report from a single center
por: Nalbandi, V, et al.
Publicado: (2001)

Evaluation of the potential adverse effects associated with calcium carbonate precipitate during continuous venovenous hemofiltration
por: McKee, J, et al.
Publicado: (2012)

The Effect of Bicarbonate Administration via Continuous Venovenous Hemofiltration on Acid-Base Parameters in Ventilated Patients
por: Allegretti, Andrew S., et al.
Publicado: (2015)

Continuous venovenous hemofiltration using customized replacement fluid for acute kidney injury with severe hypernatremia
por: Paquette, François, et al.
Publicado: (2016)

Continuous venovenous hemofiltration in the management of paraquat poisoning: A meta-analysis of randomized controlled trials
por: Lin, Guodong, et al.
Publicado: (2017)

Severe Metformin Poisoning Successfully Treated with Simultaneous Venovenous Hemofiltration and Prolonged Intermittent Hemodialysis
por: Leonaviciute, Dovile, et al.
Publicado: (2018)

Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2009)

Determinants of Outcome in Non-Septic Critically Ill Patients with Acute Kidney Injury on Continuous Venovenous Hemofiltration
por: Koning, Mark V., et al.
Publicado: (2011)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

High-volume continuous venovenous hemofiltration reduces mortality in critically ill patients with acute renal failure
por: Van Ketel, R, et al.
Publicado: (2008)

Prognostic comparison of goal-oriented hemoperfusion and routine hemoperfusion combined with continuous venovenous hemofiltration for paraquat poisoning
por: Zhao, Xuming, et al.
Publicado: (2017)

Recovery of methotrexate-induced anuric acute kidney injury after glucarpidase therapy
por: Harms, James, et al.
Publicado: (2017)

Vancomycin continuous infusion versus intermittent infusion during continuous venovenous hemofiltration: slow and steady may win the race
por: Lin, Hsin, et al.
Publicado: (2015)

Effects of leucovorin (folinic acid) in the methotrexate-treated rat brain
por: OGUSHI, Naofumi, et al.
Publicado: (2018)

Pharmacokinetics of gentamicin and vancomycin during continuous venovenous hemofiltration in critically ill septic patients with acute kidney injury
por: Petejova, N, et al.
Publicado: (2013)

Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System
por: Por, Elaine D., et al.
Publicado: (2021)

Risk factors for mortality in brain injury patients who have severe hypernatremia and received continuous venovenous hemofiltration
por: Wu, Hao, et al.
Publicado: (2023)

Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance
por: Ramsey, Laura B., et al.
Publicado: (2017)

Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study
por: Xu, Jinhui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hec6rbeekl88otns1ogq0chc3p